SQUAWK/NEWS
Account
Theme
Menu
Site Search

Search market news

Find public news by keyword, exact ticker, category and date.

News by ticker →AAPL newsSPY newsEarnings
News Feed

3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.

News 2026-09-24 10:05 UTC

BRIEF — Kyverna Therapeutics Reports Positive One — Year Data Demonstrating Durable Clinical Responses And Favorable Safety Profile For Miv — Cel In Stiff Person Syndrome And Generalized Myasthenia Gravis

Sept 24 (Reuters) — Kyverna Therapeutics, Inc.: Kyverna Therapeutics Reports Positive One-year Data Demonstrating Durable Clinical Responses And Favorable Safety Profile For Miv-cel In Stiff Person Syndrome And Generalized Myasthenia Gravis Kyverna Therapeutics, - Miv-cel Well-tolerated In Gmg Trial With No High-grade

KYTX.O
News 2026-09-24 10:02 UTC

Kyverna Therapeutics Reports Positive One-Year Data Demonstrating Durable Clinical Responses and Favorable Safety Profile for Miv-cel in Stiff Person Syndrome and Generalized Myasthenia Gravis

Topline durability data reinforce potential for single-dose miv-cel to free patients from life-long disease burden and chronic immunotherapies, further highlighting miv-cel’s differentiated constructSustained clinical benefit and reversal of disability through one year support the potential to be t…

KYTX